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SUMMARY 
Candida parapsilosis is nowadays an emerging opportunistic pathogen and its 
increasing incidence is part related to the capacity to produce biofilm. In addition, one of 
the most important C. parapsilosis pathogenic risk factors includes the organisms’ 
selective growth capabilities in hyper alimentation solutions. Thus, in this study, we 
investigated the role of glucose in C. parapsilosis biofilm modulation, by studying biofilm 
formation, matrix composition and structure. Moreover, the expression of biofilm-related 
genes (BCR1, FKS1 and OLE1) were analyzed in the presence of different glucose 
percentages. The results demonstrated the importance of glucose in the modulation of 
C. parapsilosis biofilm. The concentration of glucose had direct implications on the C. 
parapsilosis transition of yeast cells to pseudohyphae. Additionally, it was demonstrated 
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that biofilm related genes BCR1, FKS1 and OLE1 are involved in biofilm modulation by 
glucose. The mechanism by which glucose enhances biofilm formation is not fully 
understood, however with this study we were able to demonstrate that C. parapsilosis 
respond to stress conditions caused by elevated levels of glucose by up-regulating 
genes related to biofilm formation (BCR1, FKS1 and OLE1).  
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 INTRODUCTION 
Candida species are an increasingly common cause of oral infections (Williams et al., 
2011). Although Candida albicans is still the most commonly isolated, other Candida 
species such as Candida parapsilosis are increasingly reported (Martins et al., 2010; 
Moris et al., 2012). This rise in incidence is at least in part related to the organism’s 
ability to produce biofilms on medical devices (Al-Fattani & Douglas, 2006; Ramage et 
al., 2006; Silva et al., 2009b). As it is known, biofilm is a community of microbes attached 
to a surface and embedded in an extracellular matrix (Al-Fattani & Douglas, 2006; 
Ramage et al., 2006). Moreover, the most problematic characteristic of biofilms is their 
higher increased tolerance to common antifungal agents comparatively to their 
planktonic counterparts (Taff et al., 2013). Candida biofilm formation and matrix 
composition are strongly dependent on the environmental factors, such as salivary flow, 
pH and carbohydrates diet (Akpan & Morgan, 2002). In this respect, the exposure to 
different quantities of glucose influences candida biofilm formation ability and 
composition. For example, C. albicans increases the ability to produce extracellular and 
intracellular polysaccharides in response to high glucose levels, which modulates biofilm 
development and matrix composition (Santana et al., 2013). We have previously 
demonstrated that C. parapsilosis biofilms consist of a dense network of yeast and/ or 
pseudohyphae with large amounts of carbohydrates (Silva et al., 2009a). One of most 
important risk factors of the C. parapsilosis strains included the organism’s selective 
growth capabilities in hyper alimentation solutions (Almirante et al., 2006). Indeed, it has 
been demonstrated that C. parapsilosis can proliferate in high concentrations of glucose 
(Shin et al., 2002), however, it remains unclear if the presence of glucose could affect 
the biofilm development and, matrix composition as a consequence of the up-regulation 
of genes involved in biofilm formation and maturation such as cell wall regulator 1 
(BCR1), glucan synthase (FKS1) and stearoyl-coenzyme A (CoA) desaturase 1 (OLE1) 
(Nguyen et al., 2011b; Taff et al., 2012; Pannanusorn et al., 2013). 
Thus, this work aimed at studying the influence of glucose in biofilm modulation by C. 
parapsilosis strains. Specifically, elucidating the involvement of BCR1, FKS1 and OLE1 
genes in C. parapsilosis biofilm development, structure and matrix composition, in the 
presence of glucose. 
MATERIAL AND METHODS 
Organisms 
Two C. parapsilosis, one oral isolate, C. parapsilosis AD, from the collection of the 
Biofilm Group of the Centre of Biological Engineering, University of Minho (Braga, 
Portugal) and originally obtained from the Clinical of Dentistry, Congregados (Braga, 
Portugal); and a reference strain of C. parapsilosis (ATCC 22019) from the American 
Type Culture Collection (Manassas, VA, USA) were used in this work. The identity of the 
clinical isolate was initially confirmed by PCR-based sequencing using specific primers 
(ITS1 and ITS4) that are specific for the 5.8 subunit gene (Williams et al., 1995). 
 
Growth conditions 
For each experiment, strains were subcultured on Sabouraud dextrose agar (SDA) 
(Merck, Darmstadt, Germany) for 48 h at 37 °C. Cells were then inoculated in 
Sabouraud dextrose broth (SDB) (Merck) and incubated for 18 h at 37 °C under agitation 
at 120 rev min-1. After incubation, the cells were harvested by centrifugation at 3000 g for 
10 min at 4 °C and washed twice with phosphate-buffered saline (PBS, pH 7). The 
yeasts were then enumerated using an improved Neubaeur haemocytometer and 
adjusted to a concentration of 1×107 cells ml-1. The cell pellets were finally ressuspended 
in RPMI 1640 (pH 7; Sigma Saint Louis, Missouri, USA) with increase percentages of 
the glucose, 0.2, 2 and 10 % (w/v). 
 
Biofilm formation 
Biofilms were formed in 96-wells microtiter plates (orange Scientific, Braine-l´Alleud, 
Belgium). For that, standardized inoculum (200 µl of yeast cell suspension containing 
1×107 cells ml-1 in RPMI with 0.2, 2 and 10 % of glucose w/v) were placed into selected 
wells and incubated at 37 °C in an orbital shaker incubator at 120 rev min-1 during 24 h. 
Biofilm characterization 
Total biomass quantification 
Biofilm formation ability was assessed through quantification of total biomass by crystal 
violet (CV) staining (Silva et al., 2009a). After biofilm formation, the culture medium was 
aspirated and the non-adherent cells were removed by washing the biofilms once with 
PBS. Then, the biofilms were fixed with 200 µl of methanol, which was removed after 15 
min of contact. The microtiter plates were allowed to dry at room temperature, and 200 
µl of CV (1 % v/v) were added to each well and incubated for 5 min. The wells were then 
gently washed twice with sterile ultra-pure water and 200 µl of acetic acid (33 % v/v) 
added to release and dissolve the stain. The absorbance of the solution was read in 
triplicate in a microtiter plate reader (Bio-Tek Synergy HT, Izasa, Lisbon, Portugal) at 570 
nm. Experiments were repeated as part of three to five independent assays. The results 
were presented as A570 values cm-2. The strains were classified as low biofilm-forming, 
moderate biofilm-forming, and higher biofilm- forming according to their cut-offs by CV 
(<0.44; 0.44-1.17, and >1.17) (Zambrano et al., 2014). 
Quantification of cultivable cells 
The number of cultivable cells was determined by counting colony-forming units (CFUs) 
following biofilm cells ressuspension (Silva et al., 2010). Briefly, biofilms were first 
washed once with PBS to remove loosely attached cells and the biofilm was then 
ressuspended by repeated pipetting. The biofilms were removed by scrapping with the 
help of pipet tips and the complete removal was confirmed by subsequent CV staining 
and spectrophotometric reading for inspection of the wells. The ressuspended biofilm 
(500 µl) was vigorously vortexed for 5 min to disrupt the biofilm matrices and then serial 
decimal dilutions (in PBS) were plated onto SDA. Agar plates were incubated for 24 h at 
37 °C, and the total CFUs per unit area [Log (CFUs cm-2)] of microtiter plate well were 
enumerated. Experiments were repeated on three occasions with individual samples 
evaluated in triplicate.  
Biofilm structure  
The structure of biofilms was examined by scanning electron microscopy (SEM). For 
that, 2 ml of each standardized suspension (1×107 cells ml-1 in RPMI with 0.2, 2 and 10 
% of glucose) was incubated into 24-well microtiter plates (orange Scientific, Braine-
l´Alleud, Belgium) at 37 °C and 120 rev min-1. After 24 h, the medium was aspirated and 
non-adherent cells removed by washing the biofilm once with sterile ultra-pure water. 
Samples were dehydrated with alcohol (using 70 % ethanol for 10 min, 95 % ethanol for 
10 min and 100 % ethanol for 20 min) and air dried for 20 min. Samples were kept in a 
desiccator until the bases of the wells were removed using the burning scalped.  Prior to 
observation, the base of the wells was mounted onto aluminium stubs, support coated 
with gold and observed with an S-360 scanning electron microscope (Leo, Cambridge, 
USA).  
 
Biofilm matrix composition  
Extraction method and quantification 
Biofilms were formed also in 24-well microtiter plates (orange Scientific, Braine-l´Alleud, 
Belgium) for 24 h at 37 °C and 120 rev min-1 as previously described. After 24 h of 
biofilm formation the matrix was extracted using a slight modification to previously 
described protocols (Azeredo et al., 2003; Silva et al., 2009a). Briefly, biofilm samples 
were scraped from the plates, ressupended with ultra-pure water, sonicated (Utrasonic 
Processor, Cole-Parmer, IIIinois, USA) for 30 s at 30 W, and then the suspension was 
vortex for 2 min. Then, 1 ml of each suspension was filtered in a whatman membrane 
filter 0.45 μm and allowed to dry at 60 °C until constant dry biofilm weight was 
determined.  
Total carbohydrate and β-1,3 glucan quantification 
Total carbohydrate content of the biofilm matrix was estimated by the Phenol-sulfuric 
acid method according to the procedure of (DuBois et al., 1956), using glucose as 
standard. For that, 500 µl of each sample was to mix with 500 µl of phenol (50g/l) and 
2.5 ml of sulfuric acid (95%-97%). The results were presented as the mg of carbohydrate 
per g of biofilm dry weight.  
 
Matrix β-1,3 Glucan measurements 
β-1,3 glucan content in the matrix was determined using the limulus lysate assay 
Glucatell® (1,3)-b-D-glucan detection reagent kit (Associates of Cape Cod, MA), 
according the manufacturer’s instructions and as previously described (Taff et al, 2012). 
The quantity of β-1,3 glucan was measured at 405 nm and was normalized by the total 
dry weight of carbohydrates and presented as the ng of β-1,3 glucan per mg of 
carbohydrate.  
 Gene expression analysis  
Primers for real time-PCR were designed using Primer3 web-based software 
(http://biotools.umassmed.edu/bioapps/primer3_www.cgi) and are listed in Table 1. In 
order to verify the specificity of each primer pair for its corresponding target gene, PCR 
products were firstly amplified from C. parapsilosis strains genomic DNA. 
Biofilms cells RNA extraction 
For the molecular approach, biofilms of C. parapsilosis strains were grown in 24-wells 
microtiter plates (Orange Scientific, Braine-l’Alleud, Belgium) in three different 
conditions, 0.2, 2 and 10 % of glucose in RPMI, with a final concentration of 1×107 cells 
ml-1 during 24 h (as described above). After, biofilm formation the medium was aspired 
and the wells were washed once with ultra-pure water to remove non-adherent cells. 
Then, the biofilms were scraped from wells with 1 ml of PBS and sonicated (Ultrasonic 
Processor, Cole-Parmer, Illinois, USA) for 30 s at 30 W to separate the cells from the 
biofilm matrix. The cells were harvested by centrifugation at 3000 g for 10 min at 4 °C. 
RNA extraction 
RNA extraction was performed using PureLink® RNA Mini Kit (Invitrogen, Carlsbad, 
USA). Prior to RNA extraction, a lysis buffer (PureLink® RNA Mini kit) was prepared 
adding 1 % of ß-mercaptoethanol. Then, 500 µl of lysis buffer and glass beads (0.5 mm 
diameter) were added to each pellet. These mixes were homogenized twice for 30 s 
using a Mini-Bead-Beater-8 (Stratech Scientific, Soham, UK). After cells disruption, the 
PureLink® RNA Mini Kit (Invitrogen, Carlsbad, USA) was used for total RNA extraction 
according to the manufacturer’s recommended protocol. To avoid potential DNA 
contamination samples were treated with RNase-Free DNase I (Invitrogen, Carlsbad, 
USA). The RNA extraction was performed at three different independents assays. 
 
Synthesis of cDNA 
To synthesize the complementary DNA (cDNA) the iScript cDNA Synthesis Kit (Bio-Rad, 
Berkeley, USA) was used according to the manufacturer’s instructions. For each sample, 
0.5 µg of the extracted RNA was used for cDNA synthesis. cDNA synthesis was 
performed firstly to 70 °C for 5 min and then 42 °C for 1 h. The reaction was stopped by 
heating for 5 min at 95 °C.  
Quantitative Real-Time PCR (qRT-PCR) 
Real-time PCR (CF X96 Real-Time PCR System; Bio-Rad, Berkeley, USA) was used to 
determine the relative expression levels of BCR1, FKS1 and OLE1 genes concerning C. 
parapsilosis strains. ACT1 gene for C. parapsilosis was used as housekeeping gene 
(Silva et al., 2009b). Each reaction mixture consisted of a working concentration of 
SsoFast EvaGreen Supermix (Bio-Rad, Berkeley, USA), 50 µM forward and reverse 
primers, and 4 µl cDNA, in a final reaction volume of 20 µl. Negative controls, as well as, 
non-transcriptase reverse controls (NRT) were included in each run. The relative 
quantification of genes expression was performed by the Pfaffl method (Pfaffl, 2004) and 
normalized to levels of an ACT1 internal control gene as follows: ration = 
(Etarget)∆CTtarget(control-treated)/(EACT1)∆CTACT1(control-treated). Each reaction was performed in triplicate 
and mean values of relative expression were determined for each gene. 
Statistical Analysis 
Results were compared using a two-way ANOVA with the Bonferroni test, using 
GraphPad Prism 5 software. All tests were performed with a confidence level of 95 
%.RESULTS 
Influence of glucose on biofilm formation 
Biofilms formed in the presence of different concentrations of glucose were analyzed by 
complementary methodologies, total biomass using CV staining [Abs cm-2] (Fig. 1a) and 
quantification of cultivable cells [Log (CFUs cm-2)] (Fig. 1b). It was evident that both 
strains were able to form biofilm, although in different extents depending on the strain 
and amount of glucose. C. parapsilosis ATCC 22019 could be considered as a low 
biofilm-forming strain (CV <0.44) and C. parapsilosis AD as a high biofilm-forming strain 
(CV >1.1), with the C. parapsilosis clinical isolate presented 3 times more biomass than 
the reference strain (p<0.0001). 
In general, glucose enhanced biofilm formation by both strains, being more evident for 
the clinical isolate which is a strong biofilm producer, with values of CV statistically 
higher (p<0.0001) at 10 % glucose, when compared to the lower concentrations. 
The biofilms were also analyzed in terms of total amount of cultivable cells [Log (CFUs 
cm-2)] (Fig. 1b) and likewise CV results the number of cells increased with the increase 
in glucose concentration and the number of viable cells of biofilms formed by strain C. 
parapsilosis AD was significantly higher (p<0.0001) at 10 % glucose, when compared to 
the lower concentrations.  
 
Influence of glucose on biofilm structure  
In order to understand the role of glucose on biofilm ultrastructure and C. parapsilosis 
cells morphology, biofilms formed under different concentrations of glucose were 
observed by SEM (Fig. 2).  
Mature biofilms of C. parapsilosis presented different structures and cells exhibited 
different morphological characteristics depending on the strain and glucose 
concentration. Curiously, it was possible to observe that the two strains presented 
completely different biofilm structures. Candida parapsilosis ATCC 20019 biofilm, the 
weaker biofilm producer, consisted of aggregates of yeasts that increased in thickness 
with the increase of the glucose. It is important to emphasize that the oral isolate C. 
parapsilosis AD, the stronger biofilm former, despite presenting a biofilm composed by 
non-contiguous aggregates of cells, the cells switched from yeasts to pseudohyphae 
cells with the increased of glucose concentration (see arrow in Fig. 2). 
Influence of glucose on carbohydrate matrix content  
The Dubois method and Glucatell® Kit were used to determine total carbohydrates and 
specifically β-1,3 glucan contents in the matrices of biofilms formed in different 
concentrations of glucose (Table 2). 
The biofilms matrix compositions were dependent on the presence of glucose in the 
biofilms growth media. The results showed that, C. parapsilosis biofilm had high 
amounts of matrix, total carbohydrates and β-1,3 glucan with increased glucose 
concentration. In addition, the values of carbohydrates increased for ATCC 20019, but 
slightly decreased for C. parapsilosis AD between 2 and 10%. Moreover, the values of 
β,1,3 glucans were in accordance with the quantity of total carbohydrates identified with 
a stronger increase for 0.2% to 2% and 10% of the glucose for both strains. It is 
important to stress that C. parapsilosis biofilms grown in the presence of 0.2 % of 
glucose the amount of carbohydrates and β-1,3 glucans were below the detection limits. 
 
Influence of glucose in BCR1, FKS1 and OLE1 genes expression  
In order to understand how glucose modulates biofilm composition and structure, we 
assessed the expression levels of genes involved in the production of matrix 
components. Specifically we studied the relative expression levels of FKS1 gene, which 
codifies a cell-membrane enzyme that produces β-1,3 glucan, from glucose, that is 
further incorporated into the biofilm matrix; the BCR1 which codifies a regulator protein 
important for encoding biofilm matrix proteins; and the OLE1 gene that codes for the 
stearoyl-CoA desaturase that plays essential roles in lipid synthesis. The ACT1 gene, 
that is constitutively expressed, was selected as the housekeeping gene. Fig. 3 presents 
the gene expression levels of BCR1, FKS1 and OLE1 of biofilm cells grown in 0.2, 2 and 
10 % of glucose.  
Both strains of the C. parapsilosis, ATCC 20019 and AD¸ showed a tendency to increase 
the levels of expression of the three genes with the increase of glucose. In fact, biofilms 
of C. parapsilosis ATCC 20019 exhibited an up-regulation of approximately 1.5 fold of 
BCR1, more than 5 fold of FKS1 and 4 fold of OLE1 in the presence of high amounts of 
glucose. The relative expression of the 3 genes in the oral isolate C. parapsilosis AD 
presented also an up-regulation with the increase of glucose, in which it was observed a 
high increase at 10 % of glucose (almost 4 and 10 folds in FKS1 and OLE1 genes, 
respectively). 
DISCUSSION 
The success of C. paraspilosis colonization is mostly due to their ability to form biofilms. 
The human oral mucosa is exposed to different concentrations of sugars that can 
modulate biofilm formation. In fact, glucose plays an important role as energy and 
carbon source in Candida genus. In this sense, it is important to disclose how C. 
parapsilosis is able to adapt to different percentages of glucose and thus understand the 
increased number of candidiasis due to C. parapsilosis biofilms (Trofa et al., 2008). In 
this work we investigated the composition and structure of biofilms formed by two strains 
of C. parapsilosis, a collection strain and an oral isolate. Furthermore we studied the 
levels of expression of genes known to be enrolled in biofilm formation.  
The presence of glucose lead C. parapsilosis to the development of a stronger biofilm in 
terms of total biomass (Fig. 1a), especially the oral isolate that formed biofilms with 
higher amounts of viable cells (Fig. 1b) and a direct increase of carbohydrates, 
specifically β-1,3-glucan was present in the biofilms matrices (Table 2). Likewise, in C. 
albicans, BCR1 was identified as an important gene required for biofilm formation (Ding 
& Butler, 2007; Nobile et al., 2006a; Nobile & Mitchell, 2005; Nobile et al., 2006b). 
Recently, Pannanusorn and co-workers (2013) demonstrated that the transcription factor 
Bcr1p has an important role in biofilm development in strains with low biofilm formation 
abilities and a non-essential role in strains with a high level of biofilm formation 
(Pannanusorn et al., 2013). To provide insight into the role of glucose in C. parapsilosis 
biofilm development the BCR1 levels of expression were assessed (Fig. 3a). The 
molecular studies corroborated the in vitro biofilm formation studies (SEM images, Fig. 
2), once the increased level of expression of BCR1 was in accordance with the 
increased abilities to form biofilms. In addition, high expression levels of BCR1 were 
observed in the weaker biofilm producer (C. parapsilosis ATCC 20019) comparatively 
with the low levels of expression observed in the oral isolate C. parapsilosis AD, with 
high capacity to form biofilm. 
It is important to highlight that, besides promoting cell proliferation, the high percentage 
of glucose did not induce yeast toxicity. Nguyen and Nosanchuk, 2011, studied the 
behaviour of C. parapsilosis strains in stress conditions, as high levels of glucose and 
concluded that yeast cells were able to convert the excessive levels of glucose into lipid 
droplets. A specific example is the metabolism of fatty acid desaturase that involved 
Ole1p, which is essential in unsaturated fatty acids (UFA) synthesis (Nguyen & 
Nosanchuk, 2011). So, in this way the OLE1 assume an important role in responding to 
the stress conditions imposed by high glucose concentrations in C. parapsilosis (Nguyen 
et al., 2011b). We demonstrated that the expression of OLE1 gene was up-regulated 
with glucose increment (Fig. 3c), which could be explained by an attempt of yeast cells 
to protect themselves from the toxic effects of free fatty acids generated during de novo 
fatty acid biosynthesis from glucose. On the other hand, some authors have been 
advocating the importance of this gene in the development of filamentous forms by C. 
parapsilosis, due its direct implications in the fluidity and integrity of yeast membrane 
(Nguyen et al., 2011a; b). Interesting, C. parapsilosis AD biofilms formed in high glucose 
media exhibited pseudohyphae (Fig. 2) and the level of OLE1 expression was 
significantly higher comparatively to that of biofilm cells grown in low glucose contents. 
This could indicate an adaptation of the oral isolate to the oral environment with hyper 
alimentation with high levels of sugar. One of the relevant characteristics of biofilms is 
the presence of an extracellular polymeric matrix, which is generally composed by 
extracellular DNA, proteins and polysaccharides (Al-Fattani & Douglas, 2006). In this 
study, biofilm matrix was analyzed concerning total carbohydrate and β-1,3 glucan 
content (Table 2). Significantly, consistent differences were found in the composition of 
C. parapsilosis biofilms at different concentrations of glucose, with carbohydrates and β-
1,3 glucan only detected at the higher concentrations of this sugar (2.0 and 10 %). Silva 
et al., (2009) reported that matrix of C. parapsilosis consisted in high amounts of 
carbohydrates (Silva et al., 2009a). Moreover, our results demonstrated an increase of 
carbohydrates and β-1,3 glucan with the increased of glucose in the biofilm formation 
medium (Table 2).  Additionally, FKS1 gene was used to investigate the role of β-1, 3 
glucan matrix delivery. This gene has been shown previously to exhibit and important 
role on C. albicans biofilm formation (Taff et al., 2012). β-1,3 glucan besides being a 
major component of the fungal cell wall, is also present in the biofilm matrix. The 
extracellular β -1,3 glucan, has been linked to overall matrix production and drug 
resistance is catalysed by β-1,3 glucan synthase (GS1) and the gene FKS1 is 
responsible for the catalytic subunit of β-1,3 glucan synthase (Nett et al., 2007; Nett et 
al., 2010; Taff et al., 2012), which substrate is glucose. Our results pointed out that the 
presence of high levels of glucose up-regulates FKS1 leading to an increase in β-1,3 
glucan synthesis that accumulates in the biofilm matrix contributing to denser and more 
structured biofilms (Fig. 3). 
In summary, despite of the reduced number of the strains, this work demonstrates that 
glucose is able to modulate the C. parapsilosis biofilm, specifically in terms of total 
biomass, structure and carbohydrates matrix composition. Additionally, it was showed 
that biofilm related genes like as BCR1, FKS1 and OLE1 are involved in biofilm 
modulation by glucose. Nevertheless, the exact mechanism by which glucose enhance 
carbohydrate production by C. parapsilosis biofilms requires future investigation.  
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 LEGENDS TO FIGURES 
 
Fig. 1. (a) Absorbance values of crystal violet solutions (A570 CV cm-2) and (b) cell viability [Log 
(CFU cm-2)] obtained from 24 h biofilm of C. parapsilosis strains formed in RPMI with different 
concentrations of glucose expressed in % w/v. Error bars represent standard deviation. Statically 
differences obtained when compared with 0.2 % of glucose (**p<0.01, ****p<0.0001). 
 Fig. 2. Scanning electron microscopy images of the C. parapsilosis 24 h biofilms formed in RPMI 
with different concentrations of glucose. Magnification corresponds at 3000 × and the scale bars 
corresponds to 20 µm. White arrows indicated the presence of pseudohyphal forms. 
 Fig. 3. Level of gene expression (n-fold) of (a) BCR1, (b) FKS1 and (c) OLE1 in 24 h biofilm of C. 
parapsilosis cells formed in RPMI with different concentrations of glucose. The values were 
calculated using Pfaffl method, normalized by the expression of the housekeeping gene and 
compared with the genes expression at the lowest concentration of glucose (0.2 % glucose). 
Error bars represent standard deviation. Statistically differences obtained when compared with 
0.2 % of glucose (*p<0.1). 
TABLES 
Table 1. Primers used for real time-PCR analysis 
Species Sequence (5`- 3`) Primer Target 
ATCTGCGTTACCCGCAATAC Forward 
ATGTCGTCCACAAACAACGA Reverse 
ACT1 
CCATTAACCGGGTTGCTATT Forward 
GAGTCCGTTATCGCCAATGT Reverse 
BCR1 
CGACATCCACATGTCCAATC Forward 
CATTGCTGTTGCAACTTTGG Reverse 
FKS1 
TGGGGGGTAAACTAATGGGT Forward 
C. parapsilosis 
TGAAGCACCCATACCAATTG Reverse 
OLE1 
 
Table 2. Total carbohydrates and β-1, 3 glucan contents of Candida parapsilosis biofilm matrices 
growth in RPMI with different concentrations of glucose. The values are means ± standard 
deviations 
  Matrix  Carbohydrate β-1,3 glucan  
Strains 
Glucose (% 
w/v) 
mgmatrix gbiofilm-1 mgcarbohydrates gbiofilm-1 ngβ 1,3-glucanmgcarbohydrates-1 
0.2 0.0 ± 0.0* 0.0 ± 0.0* 0.0 ± 0.0* 
2 165.6 ± 11.2 13.0 ± 9.6 302.2 ± 130.4 
C. 
parapsilosis 
ATCC 
20019 10 149.3 ± 1.0 22.1 ± 9.7 339.8 ± 9.7 
0.2 0.0 ± 0.0 0.0 ± 0.0 0.0 ± 0.0 
2 130.8 ± 81.0 49.6 ± 2.7 261.7 ± 26.9 
C. 
parapsilosis 
AD 10 142.7 ± 110.6 45.7 ± 1.9 333.6 ± 27.7 
 
*Below the threshold detection level 
